Literature DB >> 1359986

Lack of feedback inhibition of insulin secretion in denervated human pancreas.

L Luzi1, A Battezzati, G Perseghin, E Bianchi, S Vergani, A Secchi, E La Rocca, C Staudacher, D Spotti, G Ferrari.   

Abstract

In this study, pancreas transplantation is used as a clinical model of pancreas denervation in humans. To assess the role of innervation on the feedback autoinhibition of insulin secretion, we studied four groups of subjects--group 1: 16 patients with combined pancreas and kidney transplantation (plasma glucose = 5.1 mM, HbA1c = 6.4%, creatinine = 86 mM); group 2: 8 patients with chronic uveitis on the same immunosuppressive therapy as transplanted patients (12 mg/day prednisone, 5 mg.kg-1.day-1 CsA); group 3: 4 uremic, nondiabetic patients in chronic hemodialysis; group 4: 7 normal, nondiabetic control subjects. The following means were used to study the groups: 1) a two-step hyperinsulinemic euglycemic clamp (insulin infusion rate = 1 mU and 5 mU.kg-1.min-1); and 2) a 0.3 mU.kg-1.min-1 hypoglycemic clamp (steady-state plasma glucose = 3.1 mM). Basal plasma-free IRI (84 +/- 6, 42 +/- 12, 72 +/- 12, and 30 +/- 6 pM in groups 1, 2, 3, and 4, respectively), basal C-peptide (0.79 +/- 0.05, 0.66 +/- 0.05, 3.04 +/- 0.20, and 0.59 +/- 0.06 nM in groups 1, 2, 3, and 4, respectively), and glucagon (105 +/- 13, 69 +/- 4, 171 +/- 10, and 71 +/- 5 pg/ml in groups 1, 2, 3, and 4, respectively) were increased in groups 1 and 3 with respect to groups 2 and 4 (P < 0.01). During euglycemic hyperinsulinemia, plasma C-peptide decreased by 45, 20, and 44% in groups 2, 3, and 4, respectively, but showed no significant change from the basal in patients with transplanted pancreases.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1359986     DOI: 10.2337/diab.41.12.1632

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  16 in total

1.  Regulation of glucose homeostasis in humans with denervated livers.

Authors:  G Perseghin; E Regalia; A Battezzati; S Vergani; A Pulvirenti; I Terruzzi; D Baratti; F Bozzetti; V Mazzaferro; L Luzi
Journal:  J Clin Invest       Date:  1997-08-15       Impact factor: 14.808

2.  Continuous glucose monitoring in subjects after simultaneous pancreas-kidney and kidney-alone transplantation.

Authors:  Luisa M Rodríguez; Richard J Knight; Rubina A Heptulla
Journal:  Diabetes Technol Ther       Date:  2010-05       Impact factor: 6.118

3.  Bilateral thoracoscopic splanchnicectomy: effects on pancreatic pain and function.

Authors:  I Ihse; E Zoucas; E Gyllstedt; R Lillo-Gil; A Andrén-Sandberg
Journal:  Ann Surg       Date:  1999-12       Impact factor: 12.969

Review 4.  Management of hyperglycaemia after pancreas transplantation: are new immunosuppressants the answer?

Authors:  Francesca M Egidi
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 5.  Recovery of endocrine function after islet and pancreas transplantation.

Authors:  Michael R Rickels
Journal:  Curr Diab Rep       Date:  2012-10       Impact factor: 4.810

6.  Combined pancreas and kidney transplantation normalizes protein metabolism in insulin-dependent diabetic-uremic patients.

Authors:  L Luzi; A Battezzati; G Perseghin; E Bianchi; I Terruzzi; D Spotti; S Vergani; A Secchi; E La Rocca; G Ferrari
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

7.  Hyperinsulinemia after pancreatic transplantation. Prediction by a novel computer model and in vivo verification.

Authors:  R C Earnhardt; D D Kindler; A M Weaver; G Cornett; D Elahi; J D Veldhuis; J B Hanks
Journal:  Ann Surg       Date:  1993-10       Impact factor: 12.969

8.  Insulin inhibits its own secretion from isolated, perifused human pancreatic islets.

Authors:  P Marchetti; D W Scharp; M McLear; E H Finke; B Olack; C Swanson; R Giannarelli; R Navalesi; P E Lacy
Journal:  Acta Diabetol       Date:  1995-06       Impact factor: 4.280

Review 9.  Glucose metabolism after pancreas-kidney transplantation.

Authors:  Elizabeth Diakoff
Journal:  Curr Diab Rep       Date:  2008-08       Impact factor: 4.810

10.  Tyramine-mediated activation of sympathetic nerves inhibits insulin secretion in humans.

Authors:  Lisa K Gilliam; Jerry P Palmer; Gerald J Taborsky
Journal:  J Clin Endocrinol Metab       Date:  2007-08-07       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.